Akari Therapeutics (AKTX) Operating Income (QoQ) (2014 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Revolution Medicines | 32.39 Bn | 32.39 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -388.32% |
| Dec 31, 2025 | 56.42% |
| Sep 30, 2025 | -137.38% |
| Jun 30, 2025 | 11.52% |
| Mar 31, 2025 | 96.85% |
| Dec 31, 2024 | -3,725.97% |
| Sep 30, 2024 | 60.71% |
| Jun 30, 2024 | -24.38% |
| Mar 31, 2024 | -17.66% |
| Dec 31, 2023 | -103.03% |
| Sep 30, 2023 | 45.68% |
| Jun 30, 2023 | -0.46% |
| Jun 30, 2022 | -10.91% |
| Mar 31, 2022 | 99.97% |
| Dec 31, 2021 | -1,398,193.70% |
| Sep 30, 2021 | 66.20% |
| Jun 30, 2021 | 21.96% |
| Mar 31, 2021 | 19.53% |
| Dec 31, 2020 | -2,693.03% |
| Sep 30, 2020 | 95.82% |
| Jun 30, 2020 | -19.98% |
| Mar 31, 2020 | 37.05% |
| Dec 31, 2019 | -151.06% |
| Sep 30, 2019 | 48.32% |
| Jun 30, 2019 | -50,521.73% |
| Mar 31, 2019 | 100.25% |
| Dec 31, 2018 | -58.49% |
| Sep 30, 2018 | 62.58% |
| Jun 30, 2018 | -85.32% |
| Mar 31, 2018 | 68.37% |
| Dec 31, 2017 | -59.35% |
| Sep 30, 2017 | -16.22% |
| Jun 30, 2017 | 11.28% |
| Mar 31, 2017 | 15.93% |
| Dec 31, 2016 | -63.64% |
| Sep 30, 2016 | 19.93% |
| Jun 30, 2016 | -95.22% |
| Mar 31, 2016 | 10.23% |
| Dec 31, 2015 | 81.61% |
| Sep 30, 2015 | -1,677.95% |
| Jun 30, 2015 | 20.71% |
| Mar 31, 2015 | -49.72% |
| Dec 31, 2014 | -406.88% |
| Sep 30, 2014 | 90.64% |
| Jun 30, 2014 | -23.74% |